We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Kronos Worldwide Hits New 52-Week High on Bright Prospects
Read MoreHide Full Article
Shares of Kronos Worldwide, Inc. (KRO - Free Report) reached a new 52-week high of $16.17 during its trading session on Mar 21. This apex improved upon the last 52-week high of $16.00 on Mar 20.
Post the release of fourth-quarter 2016 results on Mar 10, shares of the company yielded 9.52% return, outperforming the gain of 1.37% seen by the Zacks categorized Chemical Diversified industry.
On Mar 21, Kronos Worldwide closed its trading session at $15.30, yielding a year-to-date return of roughly 29.5%. The trading volume for the session was 0.71 million shares. Positive earnings estimate revisions for 2017, along with an expected earnings growth rate of 5% for the next five years indicate the stock’s potential for further price appreciation.
Growth Drivers
Kronos Worldwide’s financial performance has been impressive in three of the last four quarters, as evident from an average positive earnings surprise of 72.01%. In the fourth quarter, the company’s earnings of 16 cents per share surpassed the Zacks Consensus Estimate of 6 cents by 166.67%.
Going forward, Kronos Worldwide will benefit from the alignment of its production volumes of titanium dioxide pigments (TiO2) according to the demand in the current and near term. Also, the company will benefit from continuous rise in average production capacity utilization rates.
In addition, the company remains committed toward rewarding its shareholders handsomely through dividend payments, reflecting its solid cash position.
Estimate Revisions Show Potency
Over the last 30 days, the Zacks Consensus Estimate for Kronos Worldwide increased 122.2% to 80 cents for 2017, up 159.14% from the prior year. Also, the company has an Earnings ESP of +37.50% for 2017. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Other similarly ranked stocks in the industry include Arkema S.A. (ARKAY - Free Report) , Mitsubishi Chemical Holdings Corporation (MTLHY - Free Report) and Univar Inc. .
Arkema S.A.’s earnings estimates for 2017 have been revised upward over the last 60 days.
Mitsubishi Chemical Holdings Corporation’s earnings estimates for fiscal 2017 and fiscal 2018 have improved over the last 60 days.
Univar Inc. has an average positive earnings surprise of 18.67% for the last four quarters. Also, its earnings estimates for 2017 and 2018 improved in the last 60 days.
5 Trades Could Profit "Big-League" from Trump Policies
If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.
Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Kronos Worldwide Hits New 52-Week High on Bright Prospects
Shares of Kronos Worldwide, Inc. (KRO - Free Report) reached a new 52-week high of $16.17 during its trading session on Mar 21. This apex improved upon the last 52-week high of $16.00 on Mar 20.
Post the release of fourth-quarter 2016 results on Mar 10, shares of the company yielded 9.52% return, outperforming the gain of 1.37% seen by the Zacks categorized Chemical Diversified industry.
On Mar 21, Kronos Worldwide closed its trading session at $15.30, yielding a year-to-date return of roughly 29.5%. The trading volume for the session was 0.71 million shares. Positive earnings estimate revisions for 2017, along with an expected earnings growth rate of 5% for the next five years indicate the stock’s potential for further price appreciation.
Growth Drivers
Kronos Worldwide’s financial performance has been impressive in three of the last four quarters, as evident from an average positive earnings surprise of 72.01%. In the fourth quarter, the company’s earnings of 16 cents per share surpassed the Zacks Consensus Estimate of 6 cents by 166.67%.
Going forward, Kronos Worldwide will benefit from the alignment of its production volumes of titanium dioxide pigments (TiO2) according to the demand in the current and near term. Also, the company will benefit from continuous rise in average production capacity utilization rates.
In addition, the company remains committed toward rewarding its shareholders handsomely through dividend payments, reflecting its solid cash position.
Estimate Revisions Show Potency
Over the last 30 days, the Zacks Consensus Estimate for Kronos Worldwide increased 122.2% to 80 cents for 2017, up 159.14% from the prior year. Also, the company has an Earnings ESP of +37.50% for 2017. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Kronos Worldwide Inc Price and Consensus
Kronos Worldwide Inc Price and Consensus | Kronos Worldwide Inc Quote
Zacks Rank & Other Stocks to Consider
With a market capitalization of $1.77 billion, Kronos Worldwide currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Other similarly ranked stocks in the industry include Arkema S.A. (ARKAY - Free Report) , Mitsubishi Chemical Holdings Corporation (MTLHY - Free Report) and Univar Inc. .
Arkema S.A.’s earnings estimates for 2017 have been revised upward over the last 60 days.
Mitsubishi Chemical Holdings Corporation’s earnings estimates for fiscal 2017 and fiscal 2018 have improved over the last 60 days.
Univar Inc. has an average positive earnings surprise of 18.67% for the last four quarters. Also, its earnings estimates for 2017 and 2018 improved in the last 60 days.
5 Trades Could Profit "Big-League" from Trump Policies
If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.
Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>